Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation (Q41591704)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 March 2015
edit
Language Label Description Also known as
English
Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation
scientific article published on 19 March 2015

    Statements

    Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit